Kinemed, Inc
KineMed, a privately held biotechnology company based in Emeryville, CA, is a leader in translational and personalized medicine. KineMed uses the administration of stable (non-radioactive) isotopes to provide high-definition pharmacological measurements of disease activity and drug effects across a wide range of therapy areas, including diseases of the nervous system, metabolic and cardiovascular diseases, cancer, inflammation, and musculoskeletal diseases. KineMed is developing a focused, high-quality pipeline of its own in-licensed compounds.
7-day free trial · no credit card
Verified contacts
11
available on Kipplo
LinkedIn employees
14
11 to 50 range
Open roles
—
no listings
Distinct roles
11
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 11 verified contacts at Kinemed, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
11 contacts with verified email or phone · masked until revealed.
- DF
David Fineman
CEO & Chairman · Other
EmailPhone - MH
Marc Hellerstein
Co-founder, Chairman of Scientific Advisory Board · Other
EmailPhone - JL
Jayraz Luchoomun
Director · General Business & Management
EmailPhone - CK
Chelsea King
Sra Iv · Science
EmailPhone - TH
Tom Hirst
Private Tutor · Education
EmailPhone - DF
David Fineman
President and CEO · General Business & Management
EmailPhone
Showing 6 of 11 verified contacts
Top roles at Kinemed, Inc
11 distinct titles indexed · top 10 shown.
- 1ceo & chairman
- 1co-founder, chairman of scientific advisory board
- 1director
- 1keme
- 1kinesióloga
- 1kinesióloga a domicilio
- 1kinesiólogo
- 1president and ceo
- 1private tutor
- 1sra iii
- +1more titles
Sign up to unlock all 11 contacts at Kinemed, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 11 verified contacts at Kinemed, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.